Research Shows CBD Can Help Combat Social Anxiety Disorder Symptoms

January 7, 2020 16:00:14

Cannabidiol (CBD) is on the news yet again. For those who haven’t heard, CBD is a hemp extract that has been taking the world by storm, most especially the medical, sports, health, and wellness communities. The chemical is said to work against a ton of diseases, including anxiety, chronic pain, and high blood pressure.

A survey studying CBD use among Americans found that 20% of the people who used CBD did it to curb anxiety. Indeed, cannabis as a whole is known for its calming effects, as marijuana users can attest. However, this isn’t about your run of the mill anxiety, but a more…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.